The Health Department is offering a grant for novel research on neuropsychiatric symptoms in Alzheimer’s disease, aiming to enhance understanding of mechanisms and pathways leading to these symptoms. The research is expected to uncover new therapeutic targets for interventions to treat and prevent neuropsychiatric symptoms in Alzheimer’s disease and related dementias. Closing date for applications is May 07, 2023.
Opportunity ID: 325923
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-20-157 |
| Funding Opportunity Title: | Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer’s Dementia (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.242 — Mental Health Research Grants |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 31, 2020 |
| Last Updated Date: | Mar 31, 2020 |
| Original Closing Date for Applications: | May 07, 2023 |
| Current Closing Date for Applications: | May 07, 2023 |
| Archive Date: | Jun 12, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities For profit organizations other than small businesses Public and State controlled institutions of higher education City or township governments Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts Private institutions of higher education County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer’s disease (AD) or Alzheimer’s disease-related dementias (ADRD). The findings are expected to advance mechanistic understanding of both biobehavioral and neurobiological pathways leading to NPS. Findings may also provide insight into novel therapeutic targets that can be advanced into interventions to treat and prevent the development of NPS in AD and/or ADRD |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-20-157.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 325923 Full Announcement-PAR-20-157 -> PAR-20-157-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00260650 | May 05, 2020 | Jan 24, 2022 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277703 | Nov 01, 2022 | May 07, 2023 | View | |
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00269757 | Oct 28, 2021 | Jan 24, 2023 | View |
Package 1
Mandatory forms
325923 RR_SF424_2_0-2.0.pdf
325923 PHS398_CoverPageSupplement_5_0-5.0.pdf
325923 RR_OtherProjectInfo_1_4-1.4.pdf
325923 PerformanceSite_2_0-2.0.pdf
325923 RR_KeyPersonExpanded_2_0-2.0.pdf
325923 PHS398_ResearchPlan_4_0-4.0.pdf
325923 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
325923 RR_Budget_1_4-1.4.pdf
325923 RR_SubawardBudget30_1_4-1.4.pdf
325923 PHS398_ModularBudget_1_2-1.2.pdf
325923 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
325923 RR_SF424_5_0-5.0.pdf
325923 PHS398_CoverPageSupplement_5_0-5.0.pdf
325923 RR_OtherProjectInfo_1_4-1.4.pdf
325923 PerformanceSite_4_0-4.0.pdf
325923 RR_KeyPersonExpanded_4_0-4.0.pdf
325923 PHS398_ResearchPlan_5_0-5.0.pdf
325923 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
325923 RR_Budget_3_0-3.0.pdf
325923 RR_SubawardBudget30_3_0-3.0.pdf
325923 PHS398_ModularBudget_1_2-1.2.pdf
325923 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
325923 RR_SF424_5_0-5.0.pdf
325923 PHS398_CoverPageSupplement_5_0-5.0.pdf
325923 RR_OtherProjectInfo_1_4-1.4.pdf
325923 PerformanceSite_4_0-4.0.pdf
325923 RR_KeyPersonExpanded_4_0-4.0.pdf
325923 PHS398_ResearchPlan_4_0-4.0.pdf
325923 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
325923 RR_Budget_3_0-3.0.pdf
325923 RR_SubawardBudget30_3_0-3.0.pdf
325923 PHS398_ModularBudget_1_2-1.2.pdf
325923 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
